Pulmonary infection after colonisation with
Paeruginosa is an important cause of morbidity and mortality in patients with cystic fibrosis.' Once Paeruginosa has become established in the lungs it is never completely eradicated, even infection. This test could not identify colonised patients nor patients infected for less than six months. 2 The purpose of this study was to develop an enzyme linked immunosorbent assay to measure free serum IgG antibodies to surface antigens of Paeruginosa, which would be suitable for routine use.
Patients and methods
Sixteen patients with cystic fibrosis attending the paediatric and adult cystic fibrosis clinics at this hospital were investigated. Diagnosis of the disease was confirmed by at least one sweat test.3 In five patients with cystic fibrosis (three females, two males) Paeruginosa had never been isolated from sputum. Their age range was 1-15 years, mean (SE) was 8-4 (2-1). In seven (four females, three males) Paeruginosa had been isolated from sputum on one or more occasions during the previous year but these patients had no recognisable illness attributable to that organism. Their ages ranged from [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Serum samples 6, 7 , and 8 were diluted 1/10 000 against P aeruginosa. The blanks were 0 0100. P aeruginosa isolated continuously for at least one year from cases 6, 7, and 8$. P aeruginosa isolated intermittently from patients 4 and 5. The titre of serum from five patients with cystic fibrosis with no history of Paeruginosa infection is also shown (table 2). These titres were low. There was no correlation between titre and either age or sex. Table 3 shows the titre of serum from seven patients from whom Paeruginosa had been isolated intermittently. There was a wide spread of titres within this group of patients. Paeruginosa was isolated less than four times from cases 1-4. Titres greater than control values were present against one or two different strains in these patients. Paeruginosa had been isolated intermittently for one to two years from cases 5 and 6 and continuously for four months from case 7. In these patients titres against all serotypes were greater then those of control values. In two 1   2  3  4  5  6  7   1  115  45  570  3  85  69  200  650  6  168  154  170  295  9  75  145  300  10  76  74  80  11  71  82  140  425  600  250  Non-typable  106  100  590  Sum  71  167  168  140  1014  1334  2735  Sputum serotype  1,10  6 NT, 1
Serotypes to the international antigenic typing scheme.4 patients (cases 5 and 7) the serotype producing the highest titre was the same as the serotype isolated from sputum but this was not the case for case 6. Table 4 shows titres in four patients that grew P aeruginosa continuously for over a year. There was a wide spread of titres to individual strains. Titres were appreciably higher than those in the other groups of patients. In three of these four patients the serotype(s) producing the highest titre were those isolated from sputum.
Discussion
The purpose of this work was to develop a test, suitable for routine use, to measure the humoral immune response associated with P aeruginosa infection in patients with cystic fibrosis. Of the several antigens tested, cells treated with glutaraldehyde gave the most reproducible results and the widest spread of titres between controls and patients with cystic fibrosis chronically infected with Paeruginosa. Glutaraldehyde is a polyaldehyde that cross links the amino groups present in proteins exposed at the bacterial surface.5 These amino groups are also present in the lipopolysaccharide (in alanine and amino sugars) of the serotypes used here.6 The cells were bound to the ELISA plates by methylglyoxal. Although the mechanism of action of methylglyoxal is not known, it probably behaves like other polyaldehydes-cross linking between amino groups or by electrostatic action with polystyrene.5
In preliminary studies two or more strains of the same 0-serotype were used. Titres against each strain were within 5% on repeated tests with the same serum. Different strains of the same serotype, however, did not always give the same titre with the same serum (2-15% The results presented here show that antibodies reacting with P aeruginosa were present at very low titres both in patients with cystic fibrosis and in the control group with no known Paeruginosa infection.
Hoiby, using counterimmunoelectrophoresis, showed that the prevalence of precipitating antibodies against sonicated P aeruginosa increased gradually with age in a normal population. These antibodies, however, were present only at low titres and were directed against two antigens that cross reacted with antigens from other bacterial species. '2 In a survey of 100 adults of unspecified age, using ELISA, serum antibodies against P aeruginosa surface antigens were also present at low titres.'3 We found that patients who grew P aeruginosa continuously had very high antipseudomonal IgG antibodies, while patients who grew that organism intermittently had titres that were lower but still greater than those of the controls. There was a wide spread of titres in both groups of patients (tables 3 and 4).
The protein F (Porin) was shown to have a protective effect against infection in mice. '9 In conclusion, the assay reported here is both a sensitive and specific monitor of IgG 
